Abstract
Context: This systematic review aimed to investigate the salivary biomarkers interleukin 6 (IL-6), interleukin 1β (IL-1β), and tumor necrosis factor (TNF-α) in burning mouth syndrome (BMS) to determine whether proinflammatory cytokines are effective in causing and sustaining pain due to nerve damage and whether some salivary interleukins are elevated in BMS patients. Evidence Acquisition: A systematic review was conducted in Google Scholar, PubMed, and Scopus from 2000 to 2021. All information was categorized in tables. Results: We found 264 articles in abstract screening. After removing duplicates, 61 articles were selected. Further screening reduced the number of articles to 28. After reviewing the full texts, finally, 15 articles had the inclusion criteria and met the objectives of the present study. Conclusions: Burning mouth syndrome is a chronic disorder with an unknown origin that involves systemic and neuropathic factors. We require further studies due to inconsistent studies and very few clinical trials deciding whether there is an association between IL-6, TNF-α, and IL-1β and BMS.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Middle East Journal of Rehabilitation and Health Studies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
